Attached files
file | filename |
---|---|
EX-32 - AgeX Therapeutics, Inc. | ex32.htm |
EX-31 - AgeX Therapeutics, Inc. | ex31.htm |
EX-21.1 - AgeX Therapeutics, Inc. | ex21-1.htm |
EX-10.26 - AgeX Therapeutics, Inc. | ex10-26.htm |
EX-10.25 - AgeX Therapeutics, Inc. | ex10-25.htm |
EX-10.24 - AgeX Therapeutics, Inc. | ex10-24.htm |
EX-4.3 - AgeX Therapeutics, Inc. | ex4-3.htm |
10-K - AgeX Therapeutics, Inc. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-229432) of AgeX Therapeutics, Inc. of our report dated March 30, 2020, relating to the consolidated financial statements of AgeX Therapeutics, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & Co. LLP | |
San Francisco, California | |
March 30, 2020 |